BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAINS. ... BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAINS. SEE REMARK 350 FOR INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF A DIMER AS A SIGNIFICANT OLIGOMERIZATION STATE.
Remark 999
SEQUENCE THIS CONSTRUCT IS COMPRISED OF AMINO ACIDS 81-377 OF THE FULL-LENGTH PROTEIN (1-377) AND ... SEQUENCE THIS CONSTRUCT IS COMPRISED OF AMINO ACIDS 81-377 OF THE FULL-LENGTH PROTEIN (1-377) AND WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE FOLLOWED BY THE TARGET SEQUENCE.
モノクロメーター: Single crystal Si(111) bent (horizontal focusing) プロトコル: MAD / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray
放射波長
ID
波長 (Å)
相対比
1
0.91837
1
2
0.9792
1
反射
解像度: 2→29.696 Å / Num. obs: 56593 / % possible obs: 99.7 % / 冗長度: 7.29 % / Biso Wilson estimate: 32.83 Å2 / Rmerge(I) obs: 0.062 / Net I/σ(I): 12.89
反射 シェル
解像度 (Å)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured obs
Num. unique all
Diffraction-ID
% possible all
2-2.07
0.507
2.56
39584
9589
1
99.3
2.07-2.15
0.374
3.5
39963
9827
1
94.1
2.15-2.25
0.286
4.5
42396
10550
1
95.5
2.25-2.37
0.236
5.5
41831
10490
1
96.4
2.37-2.52
0.166
7.7
42014
10610
1
97.4
2.52-2.71
0.136
9.2
40730
10322
1
97.8
2.71-2.99
0.095
12.9
42506
10884
1
98.8
2.99-3.42
0.057
19.4
41261
10594
1
99.1
3.42-4.3
0.035
29.3
41164
10659
1
99.6
4.3-29.7
0.028
34.4
40875
1
98
-
位相決定
位相決定
手法: 多波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
MolProbity
3beta29
モデル構築
SHELX
位相決定
REFMAC
5.2.0005
精密化
XSCALE
データスケーリング
PDB_EXTRACT
2
データ抽出
MAR345
CCD
データ収集
XDS
データ削減
SHELXD
位相決定
autoSHARP
位相決定
精密化
構造決定の手法: 多波長異常分散 / 解像度: 2→29.696 Å / Cor.coef. Fo:Fc: 0.968 / Cor.coef. Fo:Fc free: 0.955 / SU B: 5.931 / SU ML: 0.084 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.126 / ESU R Free: 0.121 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE ...詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION 3. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. 4. RESIDUES 81-91, 312-315, 372-377 IN CHAIN A AND 81-91, 372-377 IN CHAIN B ARE DISORDERED AND ARE NOT MODELED. 5. LIGAND MOLECULES NAD AND TYR ARE MODELED.
Rfactor
反射数
%反射
Selection details
Rfree
0.194
2870
5.1 %
RANDOM
Rwork
0.161
-
-
-
all
0.163
-
-
-
obs
0.163
56541
99.75 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK